Reperfusion Completion Via Local Arterial Infusion of Tenecteplase After Incomplete Mechanical Thrombectomy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 344 participants.
Also called NCT07471282
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 344 participants
- Sponsor
- Chuansheng Zhao
- Registry
-
NCT07471282
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07471282. Randomized; quadruple masking; primary purpose treatment. Start 2026-03-01 (anticipated); primary completion 2028-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Reperfusion Completion Via Local Arterial Infusion of Tenecteplase After Incomplete Mechanical Thrombectomy
- Acronym
- RECLAIM-TNK
- Condition
- Stroke
- Intervention (Drug)
- Tenecteplase (0.0938mg/kg)
- Intervention (Drug)
- Placebo
- Lead sponsor
- Chuansheng Zhao
Record details
- Record id
cardio:ct-nct07471282- Content hash
1741bca71276cf5c3121af641e6432a2092e34637b59012fd5b48d689bf778c0